Analyst Ratings:
Today’s rating updates suggest a selective outlook for U.S. and Canadian stocks. Analysts raised targets for several energy, gold, health care and technology names, while airline, consumer and real estate updates were more cautious. Rising oil prices and bond yields added pressure to both equity markets on Monday. Taken together, the ratings point to opportunities in specific stocks, with broader gains likely to depend on relief from inflation and interest rate concerns.
Canadian Analyst Ratings ( 25 Entries)
5N Plus (VNP:CA) — Scotia Capital raised its target price to C$37.00 from C$35.00 while maintaining its Outperform rating.
ADF Group (DRX:CA) — Ventum Capital initiated coverage with a Buy rating and a C$20.50 target price.
Ag Growth International (AFN:CA) — CIBC lowered its target price to C$8.50 from C$19.00 while maintaining its Neutral rating.
Ag Growth International (AFN:CA) — TD Securities downgraded the stock to Hold from Buy and lowered its target price to C$11.00 from C$23.00.
AirBoss of America (BOS:CA) — TD Securities maintained its Buy rating with a C$11.00 target price.
Algoma Steel Group (ASTL:CA) — RBC Capital raised its target price to C$7.00 from C$6.00 while maintaining its Sector Perform rating.
Artemis Gold (ARTG:CA) — TD Securities raised its target price to C$44.00 from C$39.00 while maintaining its Hold rating.
B2Gold (BTO:CA) — TD Securities maintained its Buy rating with a C$8.50 target price.
Calian Group (CGY:CA) — National Bank maintained its Outperform rating with a C$100.00 target price.
Crombie REIT (CRR.UN:CA) — Desjardins Securities maintained its Buy rating with a C$18.00 target price.
Crombie REIT (CRR.UN:CA) — RBC Capital maintained its Sector Perform rating with a C$18.00 target price.
Crombie REIT (CRR.UN:CA) — TD Securities maintained its Buy rating with a C$19.00 target price.
Cronos Group (CRON:CA) — TD Securities raised its target price to C$7.00 from C$6.00 while maintaining its Buy rating.
Hudbay Minerals (HBM:CA) — TD Securities maintained its Buy rating with a C$43.00 target price.
Lightspeed Commerce (LSPD:CA) — CIBC maintained its Outperform rating with a C$25.00 target price.
Montage Gold (MAU:CA) — Canaccord Genuity changed its rating to Buy from Speculative Buy and raised its target price to C$22.50 from C$21.00.
Montage Gold (MAU:CA) — Beacon Securities raised its target price to C$26.00 from C$21.50 while maintaining its Buy rating.
NanoXplore (GRA:CA) — ATB Cormark lowered its target price to C$2.25 from C$3.00 while maintaining its Outperform rating.
SECUR3D Holdings (SRD:CNX) — Fundamental Research initiated coverage with a Buy rating and a C$0.64 target price.
Slate Grocery REIT (SGR-U:CA) — TD Securities raised its target price to C$13.00 from C$12.00 while maintaining its Sell rating.
The North West Company (NWC:CA) — CIBC maintained its Outperform rating with a C$62.00 target price.
Thesis Gold & Silver (TAU:CA) — CIBC maintained its Outperform rating with a C$6.00 target price.
Torex Gold Resources (TXG:CA) — ATB Cormark upgraded the stock to Outperform from Sector Perform and raised its target price to C$89.00 from C$71.00.
WSP Global (WSP:CA) — CIBC maintained its Outperform rating with a C$270.00 target price.
Zedcor (ZDC:CA) — ATB Cormark lowered its target price to C$9.25 from C$10.00 while maintaining its Outperform rating.
U.S. Analyst Ratings (251 Entries)
10x Genomics (TXG) — Argus initiated coverage with a Buy rating and a $110.00 price target.
10x Genomics (TXG) — Piper Sandler raised its price target to $80.00 from $47.00 and maintained a Neutral rating.
AAR (AIR) — RBC Capital Markets reiterated its Outperform rating with a $145.00 price target.
Absci (ABSI) — Guggenheim reiterated its Buy rating.
Acadia Healthcare (ACHC) — Raymond James downgraded the stock from Strong Buy to Outperform and set a $39.00 price target.
ACADIA Pharmaceuticals (ACAD) — William Blair set a $33.00 price target.
Accenture (ACN) — Susquehanna raised its price target to $153.00 from $140.00 and maintained a Neutral rating.
Acuity (AYI) — William Blair downgraded the stock from Outperform to Market Perform.
Addus HomeCare (ADUS) — Raymond James set a $137.00 price target.
ADI Global Distribution (ADIG) — Evercore initiated coverage with an In-Line rating and a $23.00 price target.
Adicet Bio (ACET) — HC Wainwright raised its price target to $34.00 from $27.00 and maintained a Buy rating.
Adicet Bio (ACET) — Wedbush reiterated its Outperform rating.
Advanced Energy Industries (AEIS) — Citigroup reiterated its Buy rating.
Agenus (AGEN) — Rodman & Renshaw initiated coverage with a Buy rating and a $19.00 price target.
Akamai Technologies (AKAM) — DA Davidson lowered its price target to $150.00 from $185.00 and maintained a Buy rating.
Alaska Air Group (ALK) — BMO Capital Markets lowered its price target to $50.00 from $62.50 and maintained an Outperform rating.
Alexandria Real Estate Equities (ARE) — BMO Capital Markets lowered its price target to $48.00 from $52.00 and maintained a Market Perform rating.
Algoma Steel Group (ASTL) — RBC Capital Markets reiterated its Sector Perform rating.
Allstate (ALL) — Piper Sandler reiterated its Overweight rating.
Alphabet (GOOG, GOOGL) — Piper Sandler raised its price target to $400.00 from $395.00 and maintained an Overweight rating for both share classes.
American Airlines Group (AAL) — BMO Capital Markets lowered its price target to $15.50 from $19.00 and maintained a Market Perform rating.
Amgen (AMGN) — Scotiabank reiterated its Outperform rating with a $500.00 price target.
AppFolio (APPF) — DA Davidson set a $240.00 price target.
Applied Materials (AMAT) — Morgan Stanley lowered its price target to $563.00 from $642.00 and maintained an Equal Weight rating.
ASML (ASML) — UBS Group reiterated its Buy rating.
AT&T (T) — Morgan Stanley raised its price target to $28.00 from $27.00 and maintained an Overweight rating.
Atlantic Union Bankshares (AUB) — Morgan Stanley raised its price target to $50.00 from $49.00 and maintained an Equal Weight rating.
Atlas Energy Solutions (AESI) — Barclays upgraded the stock from Underweight to Equal Weight and raised its price target to $14.00 from $10.00.
Atlassian (TEAM) — Robert W. Baird raised its price target to $245.00 from $200.00 and maintained an Outperform rating.
Autodesk (ADSK) — Piper Sandler resumed coverage with an Overweight rating and lowered its price target to $300.00 from $338.00.
AutoZone (AZO) — JPMorgan Chase lowered its price target to $3,700.00 from $3,850.00 and maintained an Overweight rating.
Avery Dennison (AVY) — Jefferies reiterated its Hold rating with a $181.00 price target.
Bank of America (BAC) — HSBC resumed coverage with a Buy rating and a $65.00 price target.
Bank OZK (OZK) — Morgan Stanley raised its price target to $57.00 from $56.00 and maintained an Underweight rating.
Benitec Biopharma (BNTC) — HC Wainwright reiterated its Buy rating.
Bit Digital (BTBT) — UBS Group upgraded the stock to Buy.
BlackLine (BL) — DA Davidson downgraded the stock from Neutral to Underperform and lowered its price target to $23.00 from $30.00.
Bloom Energy (BE) — RBC Capital Markets reiterated its Outperform rating with a $335.00 price target.
Boeing (BA) — Jefferies downgraded the stock from Buy to Neutral.
Braskem (BAK) — HSBC downgraded the stock from Buy to Hold and lowered its price target to $1.50 from $6.50.
Camping World (CWH) — Roth Capital reiterated its Buy rating and lowered its price target to $10.00 from $12.00.
Camtek (CAMT) — Morgan Stanley lowered its price target to $152.00 from $165.00 and maintained an Equal Weight rating.
Capital One Financial (COF) — Piper Sandler raised its price target to $260.00 from $254.00 and maintained an Overweight rating.
Carlsmed (CARL) — BTIG Research reiterated its Buy rating with a $23.00 price target.
CF Industries (CF) — Rothschild & Co Redburn upgraded the stock from Sell to Neutral and raised its price target to $110.00 from $98.00.
Charles River Laboratories International (CRL) — Jefferies raised its price target to $340.00 from $305.00 and maintained a Buy rating.
Chevron (CVX) — TD Cowen raised its price target to $215.00 from $205.00 and maintained a Hold rating.
Citigroup (C) — HSBC resumed coverage with a Buy rating and raised its price target to $164.00 from $161.00.
Citizens (CIZN) — Citigroup reiterated its Market Outperform rating.
Citizens Financial Group (CFG) — Morgan Stanley lowered its price target to $89.00 from $90.00 and maintained an Overweight rating.
Clearway Energy (CWEN) — Truist Financial lowered its price target to $40.00 from $43.00 and maintained a Buy rating.
CME Group (CME) — TD Cowen reiterated its Buy rating with a $292.00 price target.
Coca-Cola (KO) — JPMorgan Chase lowered its price target to $95.00 from $96.00 and maintained an Overweight rating.
Coinbase Global (COIN) — Keefe, Bruyette & Woods initiated coverage with an Outperform rating and a $237.00 price target.
Coinbase Global (COIN) — Robert W. Baird raised its price target to $205.00 from $130.00 and maintained a Neutral rating.
Commerce Bancshares (CBSH) — Morgan Stanley raised its price target to $77.00 from $76.00 and maintained an Overweight rating.
Constellation Brands (STZ) — Sanford C. Bernstein lowered its price target to $180.00 from $197.00 and maintained an Outperform rating.
Contineum Therapeutics (CTNM) — Morgan Stanley lowered its price target to $17.00 from $18.00 and maintained an Equal Weight rating.
Copart (CPRT) — BNP Paribas Exane reiterated its Outperform rating and raised its price target to $43.00 from $40.00.
CoreWeave (CRWV) — Cantor Fitzgerald reiterated its Overweight rating.
Costco Wholesale (COST) — Argus reiterated its Buy rating with a $1,230.00 price target.
Costco Wholesale (COST) — Deutsche Bank lowered its price target to $1,079.00 from $1,091.00 and maintained a Buy rating.
Costco Wholesale (COST) — Guggenheim reiterated its Neutral rating.
CRISPR Therapeutics (CRSP) — Citigroup reiterated its Market Outperform rating.
Cronos Group (CRON) — TD Securities reiterated its Buy rating.
Cullen/Frost Bankers (CFR) — Morgan Stanley raised its price target to $201.00 from $200.00 and maintained an Overweight rating.
Cyclerion Therapeutics (KRSA) — Guggenheim initiated coverage with a Buy rating and a $70.00 price target.
Delta Air Lines (DAL) — BMO Capital Markets lowered its price target to $100.00 from $105.00 and maintained an Outperform rating.
Devon Energy (DVN) — Wells Fargo lowered its price target to $64.00 from $65.00 and maintained an Overweight rating.
DraftKings (DKNG) — Citigroup reiterated its Market Outperform rating.
DTE Energy (DTE) — Mizuho lowered its price target to $136.00 from $152.00 and maintained an Outperform rating.
Dutch Bros (BROS) — DA Davidson lowered its price target to $60.00 from $85.00 and maintained a Buy rating.
East West Bancorp (EWBC) — Morgan Stanley raised its price target to $164.00 from $160.00 and maintained an Overweight rating.
Eli Lilly and Company (LLY) — JPMorgan Chase raised its price target to $1,500.00 from $1,400.00 and maintained an Overweight rating.
Encompass Health (EHC) — Raymond James set a $150.00 price target.
Enlight Renewable Energy (ENLT) — Truist Financial lowered its price target to $104.00 from $106.00 and maintained a Buy rating.
Envista (NVST) — BMO Capital Markets lowered its price target to $26.00 from $29.00 and maintained a Market Perform rating.
Equinor ASA (EQNR) — TD Cowen raised its price target to $41.00 from $38.00 and maintained a Hold rating.
ExxonMobil (XOM) — TD Cowen raised its price target to $180.00 from $168.00 and maintained a Buy rating.
Federal Realty Investment Trust (FRT) — Barclays lowered its price target to $118.00 from $123.00 and maintained an Equal Weight rating.
First Solar (FSLR) — Guggenheim reiterated its Buy rating.
First Solar (FSLR) — KeyBanc Capital Markets upgraded the stock from Underweight to Sector Weight.
Fiserv (FISV) — B. Riley lowered its price target to $51.00 from $66.00 and maintained a Neutral rating.
Five9 (FIVN) — DA Davidson set a $33.00 price target.
Flagstar Bank, National Association (FLG) — Morgan Stanley lowered its price target to $16.00 from $17.00 and maintained an Overweight rating.
Fortive (FTV) — Evercore initiated coverage with an In-Line rating and a $60.00 price target.
FTAI Infrastructure (FIP) — BTIG Research reiterated its Buy rating with a $9.00 price target.
FTAI Infrastructure (FIP) — JonesTrading reiterated its Buy rating with a $8.75 price target.
GRAIL (GRAL) — Canaccord Genuity raised its price target to $150.00 from $80.00 and maintained a Buy rating.
Group 1 Automotive (GPI) — Citigroup lowered its price target to $357.00 from $387.00 and maintained a Buy rating.
H. B. Fuller (FUL) — Citigroup lowered its price target to $63.00 from $75.00 and maintained a Buy rating.
H. B. Fuller (FUL) — JPMorgan Chase lowered its price target to $66.00 from $67.00 and maintained an Overweight rating.
Hexcel (HXL) — Jefferies lowered its price target to $98.00 from $110.00 and maintained a Hold rating.
Hub Group (HUBG) — Barclays lowered its price target to $30.00 from $48.00 and maintained an Equal Weight rating.
IBEX (IBEX) — Robert W. Baird raised its price target to $44.00 from $40.00 and maintained a Neutral rating.
Illumina (ILMN) — Piper Sandler raised its price target to $305.00 from $225.00 and maintained an Overweight rating.
Incyte (INCY) — HC Wainwright raised its price target to $152.00 from $150.00 and maintained a Buy rating.
Incyte (INCY) — JPMorgan Chase raised its price target to $123.00 from $120.00 and maintained a Neutral rating.
Incyte (INCY) — UBS Group reiterated its Buy rating.
IonQ (IONQ) — Bank of America initiated coverage with a Buy rating and a $60.00 price target.
IQVIA (IQV) — Truist Financial reiterated its Buy rating and raised its price target to $329.00 from $300.00.
James Hardie Industries (JHX) — Citigroup downgraded the stock from Buy to Neutral.
JetBlue Airways (JBLU) — BMO Capital Markets lowered its price target to $5.25 from $6.75 and maintained a Market Perform rating.
JPMorgan Chase & Co. (JPM) — HSBC resumed coverage with a Hold rating and raised its price target to $377.00 from $369.00.
Karman (KRMN) — RBC Capital Markets lowered its price target to $70.00 from $85.00 and maintained an Outperform rating.
Kimco Realty (KIM) — Barclays lowered its price target to $27.00 from $28.00 and maintained an Overweight rating.
Kinross Gold (KGC) — Citigroup reiterated its Buy rating.
Kodiak AI (KDK) — Cantor Fitzgerald reiterated its Overweight rating.
Kodiak Sciences (KOD) — HC Wainwright raised its price target to $96.00 from $58.00 and maintained a Buy rating.
Kodiak Sciences (KOD) — Jefferies reiterated its Buy rating.
Kodiak Sciences (KOD) — Lifesci Capital raised its price target to $145.00 from $85.00 and maintained an Outperform rating.
Kodiak Sciences (KOD) — UBS Group raised its price target to $120.00 from $80.00 and maintained a Buy rating.
Lamb Weston (LW) — Stephens lowered its price target to $50.00 from $55.00 and maintained an Equal Weight rating.
Legend Biotech (LEGN) — HC Wainwright reiterated its Buy rating.
Legend Biotech (LEGN) — UBS Group reiterated its Buy rating with a $65.00 price target.
LENSAR (LNSR) — Loop Capital set a $11.00 price target.
Lexicon Pharmaceuticals (LXRX) — Cantor Fitzgerald initiated coverage with an Overweight rating and a $8.00 price target.
Liberty Energy (LBRT) — Barclays upgraded the stock from Equal Weight to Overweight and set a $27.00 price target.
Lightspeed Commerce (LSPD) — Morgan Stanley lowered its price target to $9.50 from $11.50 and maintained an Equal Weight rating.
Linde (LIN) — Argus lowered its price target to $538.00 from $563.00 and maintained a Buy rating.
Lumentum (LITE) — Citigroup raised its price target to $1,400.00 from $1,200.00 and maintained a Buy rating.
Lumexa Imaging (LMRI) — Raymond James set a $17.00 price target.
Lumexa Imaging (LMRI) — UBS Group reiterated its Strong Buy rating.
M&T Bank (MTB) — Morgan Stanley lowered its price target to $301.00 from $304.00 and maintained an Overweight rating.
MakeMyTrip (MMYT) — Bank of America lowered its price target to $60.00 from $71.00 and maintained a Buy rating.
Manhattan Associates (MANH) — DA Davidson downgraded the stock from Buy to Neutral and set a $210.00 price target.
Manhattan Associates (MANH) — UBS Group set a $210.00 price target.
Marvell Technology (MRVL) — Cantor Fitzgerald reiterated its Neutral rating with a $330.00 price target.
Marvell Technology (MRVL) — RBC Capital Markets reiterated its Outperform rating with a $360.00 price target.
MasTec (MTZ) — Piper Sandler lowered its price target to $313.00 from $321.00 and maintained a Neutral rating.
MBX Biosciences (MBX) — UBS Group reiterated its Buy rating.
McDonald’s (MCD) — Melius Research lowered its price target to $230.00 from $250.00 and maintained a Sell rating.
McDonald’s (MCD) — Morgan Stanley lowered its price target to $297.00 from $308.00 and maintained an Equal Weight rating.
Meta Platforms (META) — Monness Crespi & Hardt raised its price target to $830.00 from $730.00 and maintained a Buy rating.
Micron Technology (MU) — Robert W. Baird raised its price target to $1,520.00 from $1,280.00 and maintained an Outperform rating.
Micron Technology (MU) — Wedbush reiterated its Outperform rating with a $1,400.00 price target.
Microsoft (MSFT) — JPMorgan Chase reiterated its Buy rating.
Mirum Pharmaceuticals (MIRM) — HC Wainwright raised its price target to $195.00 from $140.00 and maintained a Buy rating.
Mobility Global (MBGL) — JPMorgan Chase initiated coverage with a Neutral rating and a $21.00 price target.
MongoDB (MDB) — Citigroup reiterated its Market Outperform rating.
MongoDB (MDB) — William Blair reiterated its Outperform rating.
Monster Beverage (MNST) — BNP Paribas Exane reiterated its Neutral rating.
Morgan Stanley (MS) — HSBC resumed coverage with a Hold rating and raised its price target to $219.00 from $215.00.
NetEase (NTES) — Morgan Stanley reiterated its Overweight rating with a $163.00 price target.
Netflix (NFLX) — Sanford C. Bernstein reiterated its Buy rating.
NIKE (NKE) — Deutsche Bank lowered its price target to $37.00 from $45.00 and maintained a Hold rating.
NIKE (NKE) — Evercore lowered its price target to $34.00 from $46.00.
NIKE (NKE) — HSBC lowered its price target to $40.00 from $48.00 and maintained a Hold rating.
NIKE (NKE) — Jefferies reiterated its Buy rating.
NIKE (NKE) — Piper Sandler reiterated its Neutral rating and lowered its price target to $38.00 from $45.00.
NiSource (NI) — BMO Capital Markets lowered its price target to $45.00 from $49.00 and maintained an Outperform rating.
NU (NU) — Needham reiterated its Buy rating with a $19.00 price target.
NU (NU) — Rothschild & Co Redburn set a $19.00 price target.
Nutanix (NTNX) — Needham resumed coverage with a Buy rating and raised its price target to $90.00 from $85.00.
Oklo (OKLO) — Truist Financial set a $51.00 price target.
Okta (OKTA) — Citizens JMP raised its price target to $225.00 from $180.00 and maintained a Market Outperform rating.
Okta (OKTA) — Scotiabank raised its price target to $190.00 from $165.00 and maintained a Sector Outperform rating.
On Holding (ONON) — KeyCorp set a $37.00 price target with an Overweight rating.
OneMain (OMF) — Bank of America lowered its price target to $67.00 from $71.00 and maintained a Buy rating.
Ooma (OOMA) — Citigroup reiterated its Market Perform rating.
Palantir Technologies (PLTR) — Goldman Sachs reiterated its Neutral rating.
Palo Alto Networks (PANW) — BTIG Research raised its price target to $425.00 from $404.00 and maintained a Buy rating.
PAR Technology (PAR) — Needham reiterated its Buy rating with a $25.00 price target.
Park Hotels & Resorts (PK) — Raymond James upgraded the stock from Market Perform to Strong Buy and set a $19.00 price target.
Parsons (PSN) — TD Cowen reiterated its Buy rating.
Pasqal (PSQL) — Canaccord Genuity reiterated its Buy rating with a $16.00 price target.
Paychex (PAYX) — Cantor Fitzgerald lowered its price target to $96.00 from $112.00 and maintained an Underweight rating.
Paychex (PAYX) — Robert W. Baird lowered its price target to $110.00 from $125.00 and maintained a Neutral rating.
PayPal (PYPL) — UBS Group reiterated its Neutral rating.
Pebblebrook Hotel Trust (PEB) — Raymond James raised its price target to $20.00 from $18.00 and maintained an Outperform rating.
Pegasystems (PEGA) — DA Davidson downgraded the stock from Buy to Neutral and set a $32.00 price target.
PepsiCo (PEP) — Deutsche Bank downgraded the stock from Buy to Hold and lowered its price target to $138.00 from $155.00.
PepsiCo (PEP) — TD Cowen lowered its price target to $133.00 from $145.00 and maintained a Hold rating.
Phillips Edison & Company, Inc. (PECO) — Barclays lowered its price target to $43.00 from $46.00 and maintained an Equal Weight rating.
Pinnacle Financial Partners (PNFP) — Morgan Stanley raised its price target to $139.00 from $137.00 and maintained an Overweight rating.
Portland General Electric (POR) — UBS Group lowered its price target to $50.00 from $53.00 and maintained a Neutral rating.
PPL (PPL) — Wells Fargo raised its price target to $44.00 from $43.00 and maintained an Overweight rating.
Prime Medicine (PRME) — Jefferies reiterated its Market Outperform rating.
Principal Financial Group (PFG) — Piper Sandler raised its price target to $128.00 from $125.00 and maintained an Overweight rating.
Procore Technologies (PCOR) — DA Davidson set a $56.00 price target.
Procore Technologies (PCOR) — Piper Sandler initiated coverage with an Overweight rating and a $68.00 price target.
Prosperity Bancshares (PB) — Morgan Stanley raised its price target to $81.00 from $80.00 and maintained an Underweight rating.
Q32 Bio (QTTB) — Jefferies initiated coverage with a Buy rating and a $29.00 price target.
Quanta Services (PWR) — Piper Sandler lowered its price target to $714.00 from $731.00 and maintained an Overweight rating.
Rank One Computing (ROC) — Craig Hallum initiated coverage with a Buy rating and a $6.50 price target.
Regency Centers (REG) — Barclays lowered its price target to $85.00 from $92.00 and maintained an Overweight rating.
REGENXBIO (RGNX) — HC Wainwright reiterated its Buy rating.
Regions Financial (RF) — Morgan Stanley lowered its price target to $35.00 from $36.00 and maintained an Equal Weight rating.
Reinsurance Group of America (RGA) — Morgan Stanley upgraded the stock from Equal Weight to Overweight and set a $295.00 price target.
Resideo Technologies (REZI) — Evercore initiated coverage with an Outperform rating and a $30.00 price target.
Revolution Medicines (RVMD) — Brookline Capital Markets initiated coverage with a Buy rating and a $318.00 price target.
Rexford Industrial Realty (REXR) — BMO Capital Markets raised its price target to $39.00 from $38.00 and maintained an Outperform rating.
RH (RH) — Stifel Nicolaus lowered its price target to $120.00 from $130.00 and maintained a Hold rating.
Riskified (RSKD) — Truist Financial raised its price target to $9.00 from $7.50 and maintained a Buy rating.
Rivian Automotive (RIVN) — Cantor Fitzgerald reiterated its Neutral rating.
RLJ Lodging Trust (RLJ) — Raymond James downgraded the stock from Outperform to Market Perform.
Roblox (RBLX) — Jefferies downgraded the stock from Hold to Underperform and set a $38.00 price target.
Royal Caribbean Cruises (RCL) — Bank of America upgraded the stock from Neutral to Buy and set a $330.00 price target.
Royal Caribbean Cruises (RCL) — Deutsche Bank upgraded the stock from Hold to Buy and raised its price target to $330.00 from $299.00.
Royal Caribbean Cruises (RCL) — Tigress Financial reiterated its Buy rating with a $425.00 price target.
RPM International (RPM) — Morgan Stanley lowered its price target to $114.00 from $117.00 and maintained an Equal Weight rating.
Ryman Hospitality Properties (RHP) — Raymond James raised its price target to $130.00 from $125.00 and maintained an Outperform rating.
Safehold (SAFE) — Truist Financial lowered its price target to $13.00 from $17.00 and maintained a Hold rating.
Sagimet Biosciences (SGMT) — HC Wainwright reiterated its Buy rating with a $29.00 price target.
Sarepta Therapeutics (SRPT) — Needham reiterated its Underperform rating.
Scholastic (SCHL) — B. Riley lowered its price target to $35.00 from $42.00 and maintained a Neutral rating.
Selective Insurance Group (SIGI) — Piper Sandler lowered its price target to $97.00 from $105.00 and maintained a Neutral rating.
Shell (SHEL) — TD Cowen raised its price target to $115.00 from $107.00 and maintained a Buy rating.
Sherwin-Williams (SHW) — BMO Capital Markets reiterated its Outperform rating.
Simon Property Group (SPG) — Barclays lowered its price target to $208.00 from $215.00 and maintained an Equal Weight rating.
Solaris Energy Infrastructure (SEI) — Barclays raised its price target to $116.00 from $90.00 and maintained an Overweight rating.
Southwest Airlines (LUV) — BMO Capital Markets lowered its price target to $50.00 from $60.00 and maintained an Outperform rating.
SpaceX (SPCX) — CLSA initiated coverage with an Outperform rating and a $250.00 price target.
SpaceX (SPCX) — Deutsche Bank reiterated its Buy rating with a $235.00 price target.
Sphere Entertainment (SPHR) — BTIG Research reiterated its Buy rating.
Sweetgreen (SG) — Wells Fargo upgraded the stock from Equal Weight to Overweight and raised its price target to $11.00 from $6.00.
T-Mobile US (TMUS) — Sanford C. Bernstein reiterated its Neutral rating.
T. Rowe Price Group (TROW) — Evercore raised its price target to $121.00 from $113.00.
Take-Two Interactive Software (TTWO) — UBS Group set a $310.00 price target.
Tanger (SKT) — Barclays lowered its price target to $41.00 from $42.00 and maintained an Equal Weight rating.
Teleflex (TFX) — Bank of America upgraded the stock from Neutral to Buy and raised its price target to $158.00 from $145.00.
Tesla (TSLA) — Cantor Fitzgerald reiterated its Overweight rating.
Tesla (TSLA) — JPMorgan Chase lowered its price target to $415.00 from $445.00 and maintained a Neutral rating.
Tesla (TSLA) — KeyCorp upgraded the stock to Sector Weight.
The Goldman Sachs Group (GS) — HSBC resumed coverage with a Hold rating and raised its price target to $1,007.00 from $995.00.
The PNC Financial Services Group (PNC) — HSBC resumed coverage with a Buy rating and raised its price target to $283.00 from $275.00.
Transdigm Group (TDG) — BMO Capital Markets lowered its price target to $1,400.00 from $1,525.00 and maintained an Outperform rating.
Trio-Tech International (TRT) — D. Boral Capital initiated coverage with a Buy rating and a $17.00 price target.
Truist Financial (TFC) — HSBC resumed coverage with a Buy rating and a $61.00 price target.
Tyler Technologies (TYL) — Piper Sandler resumed coverage with an Overweight rating and lowered its price target to $450.00 from $491.00.
U.S. Bancorp (USB) — HSBC resumed coverage with a Buy rating and raised its price target to $76.00 from $74.00.
UiPath (PATH) — DA Davidson downgraded the stock from Neutral to Underperform and set a $10.00 price target.
UMB Financial (UMBF) — Morgan Stanley lowered its price target to $182.00 from $190.00 and maintained an Overweight rating.
United Airlines (UAL) — BMO Capital Markets lowered its price target to $140.00 from $157.50 and maintained an Outperform rating.
Valley National Bancorp (VLY) — Morgan Stanley lowered its price target to $16.00 from $17.00 and maintained an Equal Weight rating.
Vaxcyte (PCVX) — Bank of America lowered its price target to $130.00 from $133.00 and maintained a Buy rating.
Verastem (VSTM) — Cantor Fitzgerald reiterated its Overweight rating.
Vertex Pharmaceuticals (VRTX) — UBS Group raised its price target to $615.00 from $585.00 and maintained a Buy rating.
Vertiv (VRT) — Sanford C. Bernstein reiterated its Outperform rating.
Viking (VIK) — Stifel Nicolaus lowered its price target to $115.00 from $120.00 and maintained a Buy rating.
Walt Disney (DIS) — Guggenheim reiterated its Buy rating with a $120.00 price target.
Walt Disney (DIS) — Goldman Sachs reiterated its Buy rating.
WaterBridge Infrastructure (WBI) — Piper Sandler initiated coverage with an Overweight rating and a $37.00 price target.
Wells Fargo & Company (WFC) — HSBC resumed coverage with a Buy rating and a $108.00 price target.
Xencor (XNCR) — Truist Financial reiterated its Buy rating and raised its price target to $29.00 from $27.00.
Xenon Pharmaceuticals (XENE) — Jefferies reiterated its Buy rating with a $90.00 price target.
YETI (YETI) — Canaccord Genuity raised its price target to $46.00 from $45.00 and maintained a Hold rating.
Zimmer Biomet (ZBH) — BMO Capital Markets reiterated its Market Perform rating.
Zions Bancorporation, N.A. (ZION) — Morgan Stanley raised its price target to $78.00 from $77.00 and maintained an Underweight rating.
ZoomInfo Technologies (ZI) — DA Davidson set a $4.25 price target.
Zscaler (ZS) — Wedbush reiterated its Outperform rating with a $215.00 price target.
More Ratings:
The post Analyst Updates: Sept 28th, 2026 appeared first on Stock Target Advisor.
This article contains syndicated content. We have not reviewed, approved, or endorsed the content, and may receive compensation for placement of the content on this site. For more information please view the Barchart Disclosure Policy here.
